These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8384187)

  • 21. Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women.
    Horton TJ; Geissler CA
    Int J Obes Relat Metab Disord; 1996 Feb; 20(2):91-7. PubMed ID: 8646257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, double-blind, placebo-controlled study investigating the combination of acetylsalicylic acid and pseudoephedrine for the symptomatic treatment of nasal congestion associated with common cold.
    Loose I; Winkel M
    Arzneimittelforschung; 2004; 54(9):513-21. PubMed ID: 15500197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man.
    Astrup A; Toubro S
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S41-3. PubMed ID: 8384179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
    Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of aspirin, caffeine, and their combination in postoperative oral surgery pain.
    Forbes JA; Jones KF; Kehm CJ; Smith WK; Gongloff CM; Zeleznock JR; Smith JW; Beaver WT; Kroesen M
    Pharmacotherapy; 1990; 10(6):387-93. PubMed ID: 2287558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture.
    Dulloo AG; Miller DS
    J Nutr; 1987 Feb; 117(2):383-9. PubMed ID: 3559753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of weight loss, ephedrine and aspirin on energy expenditure in obese women.
    Geissler CA
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S45-8. PubMed ID: 8384180
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.
    Silberstein SD; Armellino JJ; Hoffman HD; Battikha JP; Hamelsky SW; Stewart WF; Lipton RB
    Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
    Wilding J; Van Gaal L; Rissanen A; Vercruysse F; Fitchet M;
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1399-410. PubMed ID: 15486569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weight reduction and long-term maintenance after 18 months treatment with orlistat for obesity.
    Krempf M; Louvet JP; Allanic H; Miloradovich T; Joubert JM; Attali JR
    Int J Obes Relat Metab Disord; 2003 May; 27(5):591-7. PubMed ID: 12704403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide Y in obese women during treatment with adrenergic modulation drugs.
    Zahorska-Markiewicz B; Obuchowicz E; Waluga M; Tkacz E; Herman ZS
    Med Sci Monit; 2001; 7(3):403-8. PubMed ID: 11386016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.
    Gadde KM; Parker CB; Maner LG; Wagner HR; Logue EJ; Drezner MK; Krishnan KR
    Obes Res; 2001 Sep; 9(9):544-51. PubMed ID: 11557835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity.
    Dulloo AG; Miller DS
    Am J Clin Nutr; 1987 Mar; 45(3):564-9. PubMed ID: 3825983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain.
    Nørregaard J; Jørgensen S; Mikkelsen KL; Tønnesen P; Iversen E; Sørensen T; Søeberg B; Jakobsen HB
    Clin Pharmacol Ther; 1996 Dec; 60(6):679-86. PubMed ID: 8988071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.
    Anderson JW; Greenway FL; Fujioka K; Gadde KM; McKenney J; O'Neil PM
    Obes Res; 2002 Jul; 10(7):633-41. PubMed ID: 12105285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM;
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.